Phase I clinical trial of the chimeric monoclonal antibody (c30.6) in patients with metastatic colorectal cancer.

Ward, R L; Packham, D; Smythe, A M; Murray, J; Anderson-Stewart, P; Kitchen, N; Muirhead, R; Phillips, P; Gray, P; Bigg-Wither, G; Prabakaran, K; Freund, J; Fullham, M; Rule, M; Dalley, D; Meagher, A; Hawkins, N J; Smith, G M

Ward, R L; Packham, D; Smythe, A M; Murray, J; Anderson-Stewart, P; Kitchen, N; Muirhead, R; Phillips, P; Gray, P; Bigg-Wither, G; Prabakaran, K; Freund, J; Fullham, M; Rule, M; Dalley, D; Meagher, A; Hawkins, N J; Smith, G M.

Affiliation

Ward RL; Cooperative Research Centre for Biopharmaceutical Research Ltd., Darlinghurst, New South Wales, Australia. r.ward@garvan.unsw.edu.au

Clin Cancer Res ; 6(12): 4674-83, 2000 Dec.

Article in En | MEDLINE | ID: mdl-11156219

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antibodies, Monoclonal Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Animals / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2000 Document type: Article Affiliation country: Australia Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links